Acne

A panel of 9 dermatologists met and created 5 statements regarding the role of ceramide-containing skin care products in reducing skin barrier dysfunction related to acne treatments.

Click here to answer this week's acne poll.

Catch up on acne vulgaris treatment pearls from Dermatology Times’ most recent Frontline Forum series, featuring James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD.

Learn more about the in-depth topics covered in the August 2023 Frontline Forum acne vulgaris supplement of Dermatology Times.

In the final part of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

In part 3 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

ABO blood type appeared to be a factor in severity of acne vulgaris.

In part 2 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

In part 1 of this Frontline Forum series, James Del Rosso, DO; Hilary Baldwin, MD; Neal Bhatia, MD; Christopher Bunick, MD, PhD; and Leon Kircik, MD, discuss the pathogenesis of acne vulgaris, the use of clascoterone cream 1%, differences in isotretinoin formulations, targeting sebum production, acne guidelines for patient care, and more.

With hormonal fluctuations, constantly changing schedules, and various afterschool activities, addressing the specific needs of teenage skin becomes essential to promote a lifetime of proper skin care practices.

The fractional picosecond laser had a lower incidence of adverse events compared to fractional lasers.

Researchers found that lipid profile levels were higher in patients with acne vulgaris compared to otherwise healthy patients.

In a recent study, authors argue that psychosocial impacts should be at the forefront of the discussion in acne scarring, noting that psychopharmacological management may be necessary in instances of severe psychiatric comorbidities.

During pregnancy and lactation, physiological changes occur in the body that can impact the development and management of acne.

Researchers sought to challenge the perception of microneedling as disruptive to the skin and disease states.

Bunick presented 3 sessions at the 2023 World Congress of Dermatology meeting in Singapore.

Learn more about the in-depth topics covered in the June 2023 Frontline Forum acne supplement of Dermatology Times®.

In the final part of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

In part 3 of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"

In part 2 of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

A poster presented at the 2023 SDPA Annual Summer Dermatology Conference revealed improvements to hyperpigmentation in a cohort of Black patients with moderate-to-severe acne.

In part 1 of this Frontline Forum series, Neal Bhatia, MD; Dawn Eichenfield, MD, PhD; Lawrence Eichenfield, MD; Linda F. Stein Gold, MD; and Guy Webster, MD, PhD, discuss the practical and clinical considerations in the management of acne vulgaris, reviewing available treatment options and how to treat acne scars.

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.

Cryoanesthesia was safe and reduced pain in patients receiving intralesional triamcinolone steroid injections.

Benjamin encouraged attendees at SCALE 2023 to think beyond just topicals for pediatric acne.

A plethora of oral and topical treatments are available for patients, according to Stein Gold’s SCALE 2023 sessions.

Graber discusses isotretinoin dosing and monitoring pearls at SCALE 2023.

Julie Harper, MD, shared updated risks and benefits of using spironolactone and oral contraceptives to treat acne in women at SCALE 2023.